Multiplex PCR

多重 PCR
  • 文章类型: Case Reports
    人类偏肺病毒(hMPV)是一种呼吸道病原体,可引起免疫功能正常的成年人的下呼吸道感染和肺炎。据报道,由hMPV引起的肺炎更有可能导致支气管壁增厚和毛玻璃混浊(GGO)。一名44岁无明显病史的女性出现发热,咳嗽,和恶心。胸部计算机断层扫描显示右上叶散布的GGO,左侧舌侧和双侧下叶有空气支气管图浸润的阴影。患者入院作进一步评估。怀疑为非典型肺炎,并开始使用雷舒沙星(LSFX)。多重聚合酶链反应(PCR)使用FilmArray呼吸面板2.1在医院第2天检测hMPV。怀疑由hMPV引起的肺炎,并停用LSFX。患者随后表现出自发改善,并在入院后第6天出院。放电后,肺炎继续好转。使用多重PCR早期检测呼吸道病原体可以帮助确定合适的治疗策略。由于hMPV也会引起大叶性肺炎,在大叶性肺炎的鉴别诊断中,应考虑由hMPV引起的肺炎.
    Human metapneumovirus (hMPV) is a respiratory pathogen that can cause lower respiratory tract infections and pneumonia in immunocompetent adults. Pneumonia caused by hMPV is reportedly more likely to cause bronchial wall thickening and ground-glass opacity (GGO). A 44-year-old woman with no significant medical history developed fever, cough, and nausea. Computed tomography of the chest showed scattered GGOs in the right upper lobe and infiltrating shadows with air bronchograms in the left lingual and bilateral lower lobes. The patient was admitted to our hospital for further evaluation. Atypical pneumonia was suspected and lascufloxacin (LSFX) was started. Multiplex polymerase chain reaction (PCR) detected hMPV on hospital day 2 using the FilmArray Respiratory Panel 2.1. Pneumonia due to hMPV was suspected and LSFX was discontinued. The patient subsequently showed spontaneous improvement and was discharged on hospital day 6 after admission. After discharge, pneumonia continued to improve. Early detection of respiratory pathogens using multiplex PCR can help determine the appropriate treatment strategy. As hMPV can also cause lobar pneumonia, we should consider pneumonia due to hMPV in the differential diagnosis of lobar pneumonia.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景技术耐多药革兰氏阴性菌在全球范围内的不断上升对患者安全提出了越来越大的威胁。在过去的十年里,耐碳青霉烯类肠杆菌(CRE)已成为医院获得性感染中最关键的病原体之一,特别是在重症监护室。粘菌素已经成为用于对抗由CRE引起的感染的最后的抗微生物剂之一。然而,粘菌素的使用伴随着粘菌素抗性细菌的患病率显着增加。本研究旨在研究肠杆菌顺序成员中质粒介导的粘菌素抗性基因,范围从mcr-1到mcr-8。材料和方法这项前瞻性研究于2021年5月1日至2022年7月31日在Afyonkarahisar健康科学大学健康研究与实践中心的微生物学实验室进行。从各个诊所发送的所有培养阳性临床样品中获得了总共2646种肠杆菌分离株。其中,该研究包括79个对碳青霉烯类抗生素具有抗性的分离株。在79个分离株中,在27个对粘菌素具有抗性的分离株中研究了mcr-1至mcr-8基因的存在。使用VITEK2自动化系统(bioMérieux,美国)。使用肉汤微量稀释技术(ComASP™Colistin,Liofilchem,意大利),按照制造商的说明。结果在我们的体外研究中,美罗培南的最小抑制浓度(MIC)值被确定为>8µg/ml,而粘菌素,MIC50值>16µg/ml,MIC90值为8µg/ml.在分析的79株耐碳青霉烯类肠杆菌菌株中,共鉴定出27株耐粘菌素菌株。粘菌素耐药菌株中最普遍的药物是肺炎克雷伯菌(K。肺炎),占分离株的66.7%。其次是Proteusmirabilis(P.mirabilis)与29.6%和大肠杆菌(E.大肠杆菌)占3.7%。耐碳青霉烯类菌株对粘菌素的耐药率为34.2%,通过肉汤微量稀释法测试的菌株中粘菌素的MIC值范围为4至>16µg/ml浓度。在聚合酶链反应(PCR)研究中,通过实时PCR在阳性对照分离株中成功检测到mcr-1基因区。然而,在我们使用多重PCR试剂盒调查质粒介导基因的存在的研究中,没有发现从mcr-1到mcr-8的基因区域。结论虽然我们的研究表明耐碳青霉烯类肠杆菌分离株粘菌素耐药率增加,它导致无法通过多重PCR方法检测从mcr-1到mcr-8的基因。因此,结论是,在我们地区的肠杆菌科分离物中观察到的粘菌素抗性不是由于筛选的mcr基因,而是不同的抗性发展机制。
    Background The escalating global rise in multidrug-resistant gram-negative bacteria presents an increasingly substantial threat to patient safety. Over the past decade, carbapenem-resistant Enterobacterales (CRE) have emerged as one of the most critical pathogens in hospital-acquired infections, notably within intensive care units. Colistin has become one of the last-resort antimicrobial agents utilized to combat infections caused by CRE. However, the use of colistin has been accompanied by a notable increase in the prevalence of colistin-resistant bacteria. This study aimed to investigate plasmid-mediated colistin resistance genes ranging from mcr-1 to mcr-8 among members of the Enterobacterales order. Materials and methods This prospective study was conducted in the microbiology laboratory of Afyonkarahisar Health Sciences University Health Research and Practice Center between May 1, 2021 and July 31, 2022. A total of 2,646 Enterobacterales isolates were obtained from all culture-positive clinical samples sent from various clinics. Of these, 79 isolates exhibiting resistance to carbapenem antibiotics were included in the study. Among the 79 isolates, the presence of mcr-1 to mcr-8 genes was investigated in 27 isolates that were shown to be resistant to colistin. The identification of bacteria at the species level and antibiotic susceptibility tests were conducted using the VITEK 2 automated system (bioMérieux, USA). Colistin resistance among Enterobacterales strains exhibiting carbapenem resistance was evaluated using the broth microdilution technique (ComASP™ Colistin, Liofilchem, Italy), in accordance with the manufacturer\'s instructions. Results In our in vitro investigations, the minimum inhibitory concentration (MIC) values for meropenem were determined to be >8 µg/ml, whereas for colistin, the MIC50 value was >16 µg/ml and the MIC90 value was 8 µg/ml. A total of 27 colistin-resistant strains were identified among the 79 carbapenem-resistant Enterobacterales strains analyzed. The most prevalent agent among colistin-resistant strains was Klebsiella pneumoniae (K. pneumoniae), representing 66.7% of the isolates. This was followed by Proteus mirabilis (P. mirabilis) with 29.6% and Escherichia coli (E. coli) with 3.7%. The colistin resistance rate among carbapenem-resistant strains was found to be 34.2%, with colistin MIC values in strains tested by the broth microdilution method ranging from 4 to >16 µg/ml concentrations. In polymerase chain reaction (PCR) studies, the mcr-1 gene region was successfully detected by real-time PCR in the positive control isolate. Nevertheless, none of the gene regions from mcr-1 to mcr-8 were identified in our study investigating the presence of plasmid-mediated genes using a multiplex PCR kit. Conclusion Although our study demonstrated the presence of increased colistin resistance rates in carbapenem-resistant Enterobacterales isolates, it resulted in the failure to detect genes from mcr-1 to mcr-8 by the multiplex PCR method. Therefore, it is concluded that the colistin resistance observed in Enterobacteriaceae isolates in our region is not due to the mcr genes screened, but to different resistance development mechanisms.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    本研究旨在研究临床分离的大肠杆菌多药耐药模式及其与整合子和系统发育分组的相关性。
    通过圆盘扩散法评估了总共37种临床大肠杆菌分离株的耐药性模式。通过多重PCR测定确定大肠杆菌中的系统发育分组和整合子的存在。
    在对头孢菌素(94.6%)和氟喹诺酮(83.8%)具有较高耐药性的大肠杆菌临床分离株中,发现了84%的多药耐药性,而对多粘菌素(24.3%)和碳青霉烯类(29.7%)的耐药性较低。在所有耐碳青霉烯的分离株中都发现了金属β-内酰胺酶。系统发育组B2最占优势(40.5%),其次是A组(35.1%),D(13.5%)和B1(10.8%)。在25个(67.6%)分离株中检测到整合子,在62.2%中发现了intI1、intI2和intI3基因,分别占分离株的18.9%和10.8%。
    我们的结果表明,大肠杆菌的系统发育分类与抗菌素耐药性无关。然而,整合子类别与β-内酰胺类和氟喹诺酮类抗微生物剂的耐药性之间存在很强的相关性.此外,这项研究强调,整合子的存在在大肠杆菌临床分离株的多药耐药性的发展中起着至关重要的作用.最重要的是,这是巴基斯坦大肠杆菌临床分离株中检测到三类整合子的第一份报告。
    UNASSIGNED: This study was aimed to investigate the multidrug resistance patterns in clinical isolates of Escherichia coli and their correlation with integrons and phylogenetic groupings.
    UNASSIGNED: A total of 37 clinical E. coli isolates were evaluated for drug resistance patterns by disk diffusion method. Phylogenetic groupings and the presence of integrons among E. coli were determined by multiplex PCR assays.
    UNASSIGNED: Multidrug resistance was identified in 84% of the clinical isolates of E. coli with higher resistance found against cephalosporins (94.6%) and fluoroquinolones (83.8%), while lower resistance was observed against polymyxins (24.3%) and carbapenems (29.7%). Metallo-β-lactamases were found in all carbapenem resistant isolates. The phylogenetic group B2 was the most dominant (40.5%), followed by groups A (35.1%), D (13.5%) and B1 (10.8%). Integrons were detected in 25 (67.6%) isolates and intI1, intI2, and intI3 genes were found in 62.2%, 18.9% and 10.8% of isolates respectively.
    UNASSIGNED: Our results show that phylogenetic classification of E. coli is not relevant with antimicrobial resistance. However, there was strong association between the integron classes and resistance against β-lactam and fluoroquinolones antimicrobials. Additionally, this study highlighted that the presence of integrons plays a crucial role in the development of multidrug resistance in clinical isolates of E. coli. Most significantly, this is the first report of detection of three classes of integron among clinical isolates of E. coli in Pakistan.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    镰刀菌冠腐病(FCR),由镰刀菌引起。,是小麦种植区的毁灭性疾病。以前的研究表明,FCR是由同时感染禾谷镰刀菌引起的,F.假赤霉,湖北省F.proliferatum和F.writicillioides,中国。在这项研究中,开发了一种同时检测F.graminearumDNA的方法,F.假赤霉,可以有效区分它们的F.proliferatum和F.roticillioides。这四个镰刀菌的全基因组序列比较。进行,并设计了20bp序列作为通用上游引物。还设计了每种病原体的特异性下游引物,每个病原体产生206、482、680和963bp的扩增子,分别。多重PCR专门鉴定了禾谷镰刀菌,F.假赤霉,F.增殖和轮虫,但不来自其他46种病原体,目标病原体的检测限约为100pg/μl。此外,我们使用优化的多重PCR方法准确地确定了小麦样品中的FCR病原体种类。这些结果表明,本研究建立的多重PCR方法可以高效、快速地鉴定禾谷菌株。F.假赤霉,F.增殖,和F.verticillioides,为及时、有针对性地预防和控制FCR提供技术支持。
    Fusarium crown rot (FCR), caused by Fusarium spp., is a devastating disease in wheat growing areas. Previous studies have shown that FCR is caused by co-infection of F. graminearum, F. pseudograminearum, F. proliferatum and F. verticillioides in Hubei Province, China. In this study, a method was developed to simultaneously detected DNAs of F. graminearum, F. pseudograminearum, F. proliferatum and F. verticillioides that can efficiently differentiate them. Whole genome sequence comparison of these four Fusarium spp. was performed and a 20 bp sequence was designed as an universal upstream primer. Specific downstream primers of each pathogen was also designed, which resulted in a 206, 482, 680, and 963 bp amplicon for each pathogen, respectively. Multiplex PCR specifically identified F. graminearum, F. pseudograminearum, F. proliferatum and F. verticillioides but not from other 46 pathogens, and the detection limit of target pathogens is about 100 pg/μl. Moreover, we accurately determined the FCR pathogen species in wheat samples using the optimized multiplex PCR method. These results demonstrate that the multiplex PCR method established in this study can efficiently and rapidly identify F. graminearum, F. pseudograminearum, F. proliferatum, and F. verticillioides, which should provide technical support for timely and targeted prevention and control of FCR.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    本研究评估了QIAstat-Dx呼吸道SARS-CoV-2小组(RS2P)检测呼吸道病原体的性能。对440个样本进行了RS2P测试,包括82个阴性和358个标本对1个或多个目标呈阳性(最初检测到520个目标)。在常规实验室工作流程期间在多个平台上进行初始测试。在不同的平台上重新测试在RS2P上具有不一致结果的样本,以基于2/3测定的一致性获得一致结果。正百分比,消极和总体协议(PPA,PNA,POA),计算了目标数量和CT值范围的一致性。RS2P在439个样本中产生了有效的结果,基于共识结果,POA为91.5%,16/31(51.6%)不一致标本>1阳性目标。当单个目标被检查时,PPA,PNA和POA分别为93.7%,与共识结果相比,99.9%和99.6%。总的来说,RS2P在呼吸道病原体检测中表现良好。
    This study evaluates the performance of the QIAstat-Dx Respiratory SARS-CoV-2 Panel (RS2P) for the detection of respiratory pathogens. RS2P testing was performed on 440 specimens, including 82 negatives and 358 specimens positive for 1 or more targets (520 targets initially detected). Initial testing was performed on multiple platforms during routine laboratory workflow. Specimens with discordant results on RS2P were re-tested on a different platform to obtain a consensus result based on agreement of 2/3 assays. Percent positive, negative and overall agreement (PPA, PNA, POA), as well as concordance by number of targets and CT value range were calculated. RS2P produced valid results in 439 specimens, with a POA of 91.5 % based on consensus results, with 16/31 (51.6 %) discordant specimens with >1 positive target. When individual targets were examined, PPA, PNA and POA were 93.7 %, 99.9 % and 99.6 % compared to consensus results. Overall, RS2P performed well in detection of respiratory pathogens.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    下一代测序技术和计算进步的出现扩大了我们对基因表达调控的理解(即转录组)。这也导致了人们对使用转录组生物标志物来改善疾病诊断和分层的兴趣增加。评估预后和预测治疗反应。在识别各种临床需求的转录组特征方面取得了重大进展,大量的发现研究解决了患者变异性等挑战,不需要的批处理效果,和数据复杂性;然而,与跨平台实施的技术方面相关的障碍仍然阻碍转录组学技术成功整合到标准诊断工作流程中。在这篇文章中,我们讨论了使用核酸扩增(NAA)技术将使用高通量技术(如RNA测序)获得的转录组特征整合到临床诊断工具中所面临的挑战.所提出的方法的新颖之处在于我们的目标是在签名发现过程中嵌入与跨平台实现相关的约束。这些限制可能包括扩增平台和化学的技术限制,所选择的多路复用策略施加的目标的最大数量,以及鉴定的RNA生物标志物的基因组背景。最后,我们建议建立一个计算框架,将这些约束与现有的用于签名识别的统计和机器学习模型相结合。我们设想这可以加速将高通量技术发现的RNA特征整合到适用于临床应用的基于NAA的方法中。
    The emergence of next-generation sequencing technologies and computational advances have expanded our understanding of gene expression regulation (i.e., the transcriptome). This has also led to an increased interest in using transcriptomic biomarkers to improve disease diagnosis and stratification, to assess prognosis and predict the response to treatment. Significant progress in identifying transcriptomic signatures for various clinical needs has been made, with large discovery studies accounting for challenges such as patient variability, unwanted batch effects, and data complexities; however, obstacles related to the technical aspects of cross-platform implementation still hinder the successful integration of transcriptomic technologies into standard diagnostic workflows. In this article, we discuss the challenges associated with integrating transcriptomic signatures derived using high-throughput technologies (such as RNA-sequencing) into clinical diagnostic tools using nucleic acid amplification (NAA) techniques. The novelty of the proposed approach lies in our aim to embed constraints related to cross-platform implementation in the process of signature discovery. These constraints could include technical limitations of amplification platform and chemistry, the maximal number of targets imposed by the chosen multiplexing strategy, and the genomic context of identified RNA biomarkers. Finally, we propose to build a computational framework that would integrate these constraints in combination with existing statistical and machine learning models used for signature identification. We envision that this could accelerate the integration of RNA signatures discovered by high-throughput technologies into NAA-based approaches suitable for clinical applications.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    不同自然抗病性等位基因的部署是番茄多病管理的最可持续和生态友好的方式。诊断分子标记在这项工作中是必不可少的,因为它们以不依赖环境的方式提供了抗性等位基因的早期鉴定。此外,优化的多重聚合酶链反应(PCR),用于在单个反应中检测不同的抗病等位基因,可以加快选择过程,具有成本和劳动效率。在这里,我们报告了番茄基因型和F2分离株中抗卷曲病等位基因Ty-2和Ty-3以及抗晚疫病等位基因Ph-3的优化多重检测和堆叠。三链体测定可以被双链体测定(对于Ty-2和Ty-3抗性等位基因)替代,随后在Ph-3基因座处进行分析以实现进一步的成本效益。我们鉴定了源自ArkaSamrat(F1)xKashiChayan组合的F2种群中的两种植物,它们在纯合条件下携带Ty-2,Ty-3和Ph-3抗性等位基因。早期基因分型也使我们能够鉴定出一些形态更好的分离物,其中进一步的标记辅助选择(MAS)应确定优良的多重抗病系。因此,我们主张在MAS中使用多重PCR来解决番茄的多重抗病育种。
    Deployment of different natural disease resistance alleles is the most sustainable and eco-friendly way for multiple disease management in tomato. Diagnostic molecular markers are indispensible in this effort as they offer early generation identification of resistance alleles in an environment-independent manner. Moreover, optimized multiplex polymerase chain reaction (PCR) for detecting different disease resistance alleles in a single reaction can speed-up the selection process with cost and labour-effectiveness. Here we report the optimized multiplex detection and stacking of leaf curl disease resistance alleles Ty-2 and Ty-3 along with late blight disease resistance allele Ph-3 in tomato genotypes and F2 segregants. The triplex assay could be replaced by a duplex assay (for Ty-2 and Ty-3 resistance alleles) followed by analysis at Ph-3 locus to achieve further cost-effectiveness. We identified two plants in F2 populations derived from the Arka Samrat (F1) x Kashi Chayan combination to carry the Ty-2, Ty-3 and Ph-3 resistance alleles in homozygous condition. Early generation genotyping also allowed us to identify a few morphologically better segregants, where further marker assisted selection (MAS) should identify superior multiple disease resistant lines. Thus we advocate the utility of multiplex PCR in MAS to address multiple disease resistance breeding in tomato.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    报告1例合并弓形虫(Tg)和爱泼斯坦巴尔病毒(EBV)感染的类风湿关节炎和免疫抑制生物治疗的糖尿病患者。
    一名70岁女性,有类风湿性关节炎病史,正在接受皮质类固醇治疗,甲氨蝶呤,和abatacept表现为双侧肉芽肿性葡萄膜炎,伴有视网膜坏死和黄斑受累。诊断性玻璃体切除术检测到Tg和EBV。用克林霉素治疗,甲氧苄啶-磺胺甲恶唑,阿昔洛韦成立了,实现改进。
    接受免疫抑制治疗的患者存在机会性感染的风险,常表现为严重和不典型的临床表现。在这种情况下,多重聚合酶链式反应是一种非常有价值的诊断工具,可以帮助识别所涉及的特定病原体。这使医疗保健专业人员能够做出明智的治疗决定,并为每种已识别的病原体提供靶向治疗。
    UNASSIGNED: To report a case of coinfection of Toxoplasma gondii (Tg) and Epstein Barr Virus (EBV) in a diabetic patient with rheumatoid arthritis and immunosuppressive biological therapy.
    UNASSIGNED: A 70-year-old female with a history of rheumatoid arthritis on therapy with corticosteroids, methotrexate, and abatacept presented bilateral granulomatous panuveitis associated with retinal necrosis and macular involvement. A diagnostic vitrectomy detected Tg and EBV. Treatment with clindamycin, trimethoprim-sulfamethoxazole, and acyclovir was established, achieving improvement.
    UNASSIGNED: Patients undergoing immunosuppressive therapy are at risk of developing opportunistic infections, often presenting with severe and atypical clinical manifestations. In such cases, multiplex polymerase chain reaction is an invaluable diagnostic tool that helps identify the specific pathogens involved. This enables healthcare professionals to make informed treatment decisions and provide targeted therapy for each identified pathogen.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    我们介绍multiPrime,一种新颖的工具,可以自动设计用于靶向下一代测序的最小引物集,针对特定的微生物组或基因。MultiPrime通过设计具有错配耐受性的引物来增强引物覆盖率,并确保高兼容性和特异性。我们使用来自八种病毒的43,016个序列的数据集评估了multiPrime的性能。我们的结果表明,multiPrime优于传统工具,并且由multiPrime设计的引物组成功地扩增了目标扩增子。此外,我们将multiPrime的应用扩展到30种病毒,并在80份临床标本中验证了multiPrime设计引物的工作效能.来自这些引物的后续测序结果表明94%的灵敏度和89%的特异性。
    We present multiPrime, a novel tool that automatically designs minimal primer sets for targeted next-generation sequencing, tailored to specific microbiomes or genes. MultiPrime enhances primer coverage by designing primers with mismatch tolerance and ensures both high compatibility and specificity. We evaluated the performance of multiPrime using a data set of 43,016 sequences from eight viruses. Our results demonstrated that multiPrime outperformed conventional tools, and the primer set designed by multiPrime successfully amplified the target amplicons. Furthermore, we expanded the application of multiPrime to 30 types of viruses and validated the work efficacy of multiPrime-designed primers in 80 clinical specimens. The subsequent sequencing outcomes from these primers indicated a sensitivity of 94% and a specificity of 89%.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    胃肠炎约占儿童死亡人数的10%,尤其是免疫功能低下的儿童。在伊朗,有关RNA病毒引起的胃肠道感染患病率的研究很少。该研究的目的是使用多重PCR评估引起腹泻的RNA病毒的检测。
    收集了130名患有急性淋巴细胞白血病的腹泻患儿的粪便样本,非霍奇金淋巴瘤,和视网膜母细胞瘤.RNA提取和cDNA合成后,进行多重PCR以评估轮状病毒的存在,诺如病毒,星状病毒,和肠道病毒。
    有9个(6.9%),7(5.4%),3(2.3%),和6例(4.6%)轮状病毒,诺如病毒,星状病毒,检测到肠道病毒,分别。观察到1例星形病毒和诺如病毒共同感染。
    这是伊朗的第一份报告,该报告确定了在免疫功能低下的儿童中存在引起腹泻的常见RNA病毒。提高对这些病毒的认识将使医疗保健专业人员能够改进策略和政策,以控制由这些病毒引起的传播和感染。
    UNASSIGNED: Gastroenteritis accounts for about 10% of the deaths among children, especially in immunocompromised children. Few studies on the prevalence of gastrointestinal infections caused by RNA viruses have been done in Iran. The aim of the study was to evaluate the detection of RNA viruses causing diarrhoea using a multiplex PCR.
    UNASSIGNED: Stool samples were collected from 130 paediatric patients with diarrhoea who had acute lymphocytic leukaemia, non-Hodgkin lymphoma, and retinoblastoma. After RNA extraction and synthesis of cDNA, multiplex PCR was done to evaluate the presence of rotavirus, norovirus, astrovirus, and enterovirus.
    UNASSIGNED: There were 9 (6.9%), 7 (5.4%), 3 (2.3%), and 6 (4.6%) cases of rotavirus, norovirus, astrovirus, and enterovirus detected, respectively. One case of co-infection with astrovirus and norovirus was observed.
    UNASSIGNED: This is the first report from Iran which identified the presence of common RNA viruses causing diarrhoea in immunocompromised children. Increased awareness of these viruses will enable healthcare professionals to improve strategies and policies to control spread and infection caused by these viruses.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号